Skip to main content

IPG PHOTONICS CORP

For the period ended Dec 31, 2023. Filed Feb 21, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 21, 2024

IPGP$70.67+8.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 2. PROPERTIES

Our significant facilities at December 31, 2023 include the following:

LocationOwned orLeasedLease ExpirationApproximateSize (sq. ft.)Primary Activity
Oxford, MassachusettsOwned550,300Diodes, components, final assembly, complete device manufacturing, R&D, administration
Burbach, GermanyOwned567,100Optical fiber, components, final assembly, complete device manufacturing, R&D, administration
LeasedMay 20271,500Complete device manufacturing
Fryazino, RussiaOwned496,000Optical fiber, components, final assembly, complete device manufacturing, R&D, administration
LeasedNovember 202620,000Components
Marlborough, MassachusettsOwned377,800Components, systems manufacturing, applications, sales, R&D, administration
Minsk, BelarusOwned372,100Manufacturing of cabinets and mechanical subcomponents
Davenport, IowaOwned160,300Systems integration, sales, administration

Our corporate headquarters is in Marlborough, Massachusetts. As of December 31, 2023, we occupied more than 3.3 million square feet of facilities worldwide. Of this we own 2.9 million square feet and lease 0.4 million square feet of building space, of which the majority is used for manufacturing. Our major manufacturing facilities are located in the United States and Germany. We have substantially reduced our reliance on our Russian operations, and have ceased new investments in our Russian and Belarus operations. We have and will continue to expand our manufacturing operations in Germany and the United States, and have added manufacturing capacity in Italy and Poland to meet the demand for our products and our sales and support needs. We conduct our major research and development activities in Oxford and Marlborough, Massachusetts and Burbach, Germany.

We own additional facilities and land for various purposes, such as sales and support and applications labs. We believe the existing facilities are in good operating condition and are suitable for the conduct of our operations.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.